{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Around the Circle: Living Well with T1D","title":"Diana Isaacs and Natalie Bellini on Translating the Latest Diabetes Research into Real Life","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/6a48afbb\"></iframe>","width":"100%","height":180,"duration":4059,"description":"Natalie Bellini, DNP,  BC-ADM, CDCES and Diana Isaacs, PharmD, BCACP, BC-ADM, CDCES join Scott to cut through the noise of the American Diabetes Association’s (ADA) Scientific Sessions for an hour-long special! For many people living with type 1 diabetes, this annual conference can feel like a dense academic event designed strictly for clinicians and researchers. However, in this episode, Natalie and Diana break down a few highlights and talk about what they mean for daily life with T1D.\nThey explore some of the most exciting developments presented at the conference, including advancements in islet cell transplants, the promise of Continuous Ketone Monitoring (CKM), and the evolving role of GLP-1s and inhaled insulin in T1D management. It’s a candid, realistic look at what’s on the horizon, what’s still experimental, and how to filter out the headlines to focus on tools that will actually improve your quality of life. And while these are great actionable takeaways, you should always consult with your personal healthcare team before making any changes to your treatment plan.\n\nWhat You'll Learn\nTranslating Research: Why ADA Scientific Sessions matter for people with T1D and how to think about \"bench research\" versus tools you might actually see in your doctor's office soon.\nIslet Cell Transplants: Updates on the Eledon trial and the use of Tegoprubart to reduce the burden of traditional, harsh immunosuppression.\nContinuous Ketone Monitoring (CKM): How a new sensor (like the Libre Duo) could revolutionize DKA detection and prevention for both adults and children.\nSGLT2 Inhibitors: Understanding the benefits and risks of these medications in type 1 diabetes, specifically regarding euglycemic DKA.\nInhaled Insulin: How inhaled insulin is expanding to pediatric use, what that means for adults with T1D, and practical ways it can be used for \"rescue\" dosing or meal management alongside traditional insulin delivery therapy.\nGLP-1s in T1D: Why these hormones are a hot...","thumbnail_url":"https://img.transistorcdn.com/ZwtJk5cNfIfgz2P3gzr9JcObYabO_Mtb5PIacekPQ7A/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zNTk3/NjFhNWRiZjNkMTEw/MTg4NzAyMDkwMWI1/MDk5YS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}